YOLFTbeta
PeterLabs Holdings Bhd

PeterLabs Holdings Bhd

0171 · KLSE · Healthcare / Drug Manufacturers - Specialty & Generic

0.235MYR+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close0.235
Open0.235
Day Range0.235 – 0.235
52-Week Range0.16 – 0.28
Volume100
Market Cap60.55M
P/E (TTM)22.00
Forward P/E0.00
EPS0.01
Dividend Yield0.00%
Beta0.39
50-Day Avg0.2259
200-Day Avg0.2449

About

PeterLabs Holdings Berhad, an investment holding company, engages in manufacturing, distribution, trading, and export of animal health and nutrition products in Malaysia and internationally. The company operates through three segments: Manufacturing, Trading, and Others. It offers biosecurity products and disinfectants, compound feed supplements, feed additives, nutritional premixes, pharmaceuticals, and water-soluble supplements. The company also engages in the distribution of consumer goods, including home care, oral care, baby care, and feminine care products, as well as grain products, and processed foods and beverage products to retailers, such as supermarkets, mini markets, sundry shops, convenience stores, pharmacies, petrol kiosks, Chinese medical halls, and hardware stores. The company was founded in 2002 and is headquartered in Nilai, Malaysia.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Tong Seng Lim
  • Employees0
  • HeadquartersJalan Nilam 3, Nilai, Malaysia, 71800, Malaysia
  • Websitehttps://www.peterlabs.com.my

Leadership

  • Mr. Tong Seng LimCo-Founder, Group MD & Director · b. 1959
  • Mr. Chin Heng TeoCo-Founder, Head of Supply Chain Department & Executive Director · b. 1953
  • Ms. Siaw Peng YapExecutive Director · b. 1973
  • Mr. Boon Siong NgExecutive Director · b. 1985
  • Mr. You Cheong LiewExecutive Director · b. 1977
  • Ms. Lai Yee NgCompany Secretary

Financials

Income Statement

Currency: MYR2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31
Total Revenue73.48M83.58M94.73M90.42M96.23M80.03M183.82M161.63M186.21M242.21M
Growth (%)-+13.74%+13.35%-4.56%+6.43%-16.84%+129.71%-12.07%+15.20%+30.07%
Cost of Revenue58.40M66.63M77.65M72.81M78.27M64.82M158.01M141.05M166.85M212.94M
Gross Profit15.09M16.94M17.09M17.61M17.97M15.21M25.81M20.58M19.36M29.27M
Gross Margin20.53%20.27%18.04%19.48%18.67%19.00%14.04%12.74%10.40%12.08%
Operating Expense9.56M11.32M10.84M11.36M11.73M9.50M16.89M15.55M16.60M24.89M
Operating Income5.53M5.63M6.25M6.25M6.23M5.71M8.93M5.03M2.76M4.38M
Operating Margin7.52%6.73%6.60%6.91%6.47%7.13%4.86%3.11%1.48%1.81%
EBITDA--7.81M8.00M8.21M7.69M11.47M7.10M6.19M4.73M
EBITDA Margin--8.24%8.84%8.54%9.61%6.24%4.39%3.32%1.95%
Net Income3.34M3.33M4.01M3.80M4.28M3.89M5.48M3.60M1.39M2.29M
Net Income Margin4.55%3.99%4.23%4.20%4.44%4.86%2.98%2.23%0.74%0.94%
Interest Expense000797.15K522.69K268.67K851.68K504.29K764.00K762.00K
Interest Expense % of Total Revenue0.00%0.00%0.00%0.88%0.54%0.34%0.46%0.31%0.41%0.31%

Balance Sheet

Currency: MYR2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31
Total Assets50.50M61.75M68.92M72.81M72.73M73.43M111.57M106.22M112.91M111.03M
Total Liabilities11.51M22.32M23.18M24.55M20.26M15.07M39.15M31.85M37.15M34.09M
Total Equity38.99M39.43M45.74M48.26M52.47M58.36M72.42M74.37M75.76M76.94M
Cash-5.57M7.03M5.59M14.78M24.31M14.15M10.30M16.10M10.56M
Total Debt-6.06M5.19M8.36M7.39M990.00K----
Net Debt--5.69M2.81M--1.37M-2.46M3.31M

Cash Flow

Currency: MYR2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31
Operating Cash Flow-1.06M8.31M1.82M1.57M10.57M9.78M-4.74M111.00K5.42M12.39M
Investing Cash Flow-1.58M-6.70M-1.11M-133.84K-22.13K-95.86K-1.99M-64.00K-7.81M-14.03M
Financing Cash Flow2.03M353.17K747.32K-2.90M-1.38M-127.39K-3.53M-3.79M8.20M-3.86M
Capital Expenditure1.62M6.94M1.16M201.28K22.13K309.86K387.27K259.00K8.11M14.62M
Free Cash Flow--662.86K1.37M10.55M9.47M-5.12M6.13M-2.70M1.69M
Dividends Paid940.00K2.90M01.29M2.36M2.36M1.65M1.65M01.10M
FCF to OCF--36.36%87.16%99.79%96.83%108.18%5526.01%-49.83%13.62%
Dividend Paid to FCF--0.00%94.28%22.40%24.93%-32.23%26.92%0.00%65.26%

Earnings

Report DateSep 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Jun 30, 2014Sep 30, 2014Dec 31, 2014Mar 31, 2015Jun 30, 2015Sep 30, 2015Dec 31, 2015Mar 31, 2016Jun 30, 2016Sep 30, 2016Dec 31, 2016Mar 31, 2017Jun 30, 2017Sep 30, 2017Dec 31, 2017Mar 31, 2018Jun 30, 2018Sep 30, 2018Dec 31, 2018Mar 31, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Mar 31, 2020Jun 30, 2020Sep 30, 2020Dec 31, 2020Mar 31, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate------------------------------------------------------------
EPS Actual0.000.000.000.000.010.000.000.000.000.000.000.000.000.010.000.000.010.000.000.000.010.000.000.000.000.010.000.000.000.010.000.000.010.010.000.000.010.000.010.000.010.010.000.000.000.000.000.000.000.000.000.000.010.000.00-0.010.01-0.00-0.00-0.01
Surprise------------------------------------------------------------
Timing------------------------------------------------------------

Key Statistics & Ratios

Market Cap60.55M
Enterprise Value70.40M
Trailing P/E22.00
Forward P/E0.00
Price / Sales0.56
Price / Book0.81
EPS0.01
Book Value0.274
Revenue (TTM)107.66M
Gross Profit (TTM)16.46M
EBITDA-379.00K
Profit Margin-1.47%
Operating Margin-10.28%
Return on Equity-2.78%
Return on Assets-1.22%
Shares Outstanding275.21M
Shares Float68.29M
Beta0.39
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio38.83%

Dividends

20241×
0.00Mar 21, 2024
20221×
0.01Jul 14, 2022
20201×
0.01Oct 1, 2020
20181×
0.01Jan 17, 2018
20162×
0.01Dec 28, 20160.01Feb 29, 2016
20151×
0.01Feb 5, 2015
20141×
0.00Jan 28, 2014
20131×
0.01Mar 14, 2013
20121×
0.01Jan 5, 2012